Similar to TNFα, it has recently been demonstrated that circulating levels of this cytokine are elevated in human patients with active pulmonary tuberculosis, and that these levels decline significantly over a six month course of therapy54. This evidence concerns the gene TNF and pulmonary tuberculosis.